Treace Medical Concepts (TMCI) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Treace Medical Concepts (TMCI) is Moderate Underperform.

The composite score behind that read is -0.30, weighing +0.49 of bullish evidence against -0.35 bearish.

Treace Medical Concepts last closed at $4.48, +2.05% on the session.

Against the IVW growth benchmark the position is +1.13% over the forecast window.

The read is built from 12 underlying insights — 1 bullish and 11 bearish.

Agreement across those insights is 92%.

15 graded predictions for TMCI so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Treace Medical Concepts in the 14th percentile on return on equity, where 100 is best.

Treace Medical Concepts is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $285.50M.

StockMap tracks Treace Medical Concepts as the 86th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Treace Medical Concepts ranks 104th of 133 in the group, against a group median of -0.21.